STOCKHOLDERS' EQUITY - 2020 Plan and ESPP (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| STOCKHOLDERS' EQUITY | |||
| Shares remain available for future issuance | 235,406 | ||
| 2020 Plan | |||
| STOCKHOLDERS' EQUITY | |||
| Common stock issuable (in shares) | 10,200,000 | ||
| Common stock remain available for future grants | 3,185,260 | ||
| Performance-based awards | |||
| STOCKHOLDERS' EQUITY | |||
| Vesting in the period (in shares) | 1,536,258 | ||
| Remaining vested provisions | 939,089 | ||
| Share-based compensation expense | $ 0.3 | $ 7.9 | |
| Performance-based awards | Minimum [Member] | |||
| STOCKHOLDERS' EQUITY | |||
| Vesting percentage (in %) | 80.00% | ||
| Remaining vested term | 1 year | ||
| Performance-based awards | Maximum | |||
| STOCKHOLDERS' EQUITY | |||
| Vesting percentage (in %) | 200.00% | ||
| Remaining vested term | 3 years | ||
| 2020 Employee Stock Purchase Plan | |||
| STOCKHOLDERS' EQUITY | |||
| Common stock issuable (in shares) | 500,000 | ||
| Shares issued (in shares) | 76,256 | 89,923 | |
| X | ||||||||||
- Definition Remaining vested term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that remains vested during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of vesting of award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of an employee stock purchase plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|